Skip to main content
  • Hemorrhagic MI Biomarker Could Predict Heart Failure or Sudden Death Risk, Study Concludes

    Hemorrhagic myocardial infarction (MI) can be diagnosed by a blood biomarker, which could predict adverse risk of acute outcomes, such as heart failure and sudden death, according to a new study.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details